Abstract
Intraoperative monitoring (IOM) may generally be separated into two categories: (1) evaluating real-time data to detect adverse changes in the nervous system giving the surgical team a chance either to reverse or to stop what is causing the change; (2) evaluating real-time data to help determine related physiological localization or guidance for the surgical team through specific procedural steps of a particular surgery. In both categories the surgical, anesthetic, and neuromonitoring personnel play a role in how the data is interpreted and incorporated during the procedure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Umemura A, Jaggi JL, Hurtig HI, et al. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg. 2003;98(4):779–84.
Apetauerova D, Schirmer CM, Shils JL, et al. Successful bilateral deep brain stimulation of the globus pallidus internus for persistent status dystonicus and generalized chorea. J Neurosurg. 2010;113(3):634–8.
Bekker AY, Kaufman B, Samir H, Doyle W. The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg. 2001;92:1251–3.
Ruskin DN, Bergstrom DA, Kaneoke Y, et al. Multisecond oscillations in firing rate in the basal ganglia: robust modulation by dopamine receptor activation and anesthesia. J Neurophysiol. 1999;81:2046–55.
Hutchison WD, Lozano AM. Microelectrode recordings in movement disorder surgery. In: Lozano AM, editor. Movement disorders surgery. Basel: Karger; 2000. p. 103–17.
Bohmdorfer W, Schwarzinger P, Binder S, et al. Temporary suppression of tremor by remifentanil in a patient with Parkinson’s disease during cataract extraction under local anesthesia. Anaesthesist. 2003;52:795–7.
Burton DA, Nicholson G, Hall GM. Anaesthesia in elderly patients with neurodegenerative disorders: special considerations. Drugs Aging. 2004;21:229–42.
Krauss JK, Akeyson EW, Giam P, et al. Propofol-induced dyskinesias in Parkinson’s disease. Anesth Analg. 1996;83:420–2.
Ard J, Doyle W, Bekker A. Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesthesiol. 2003;15:263–6.
Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev. 2003;42:33–84.
Almeida AN, Tavares C, Tibano A, et al. Dexmedetomidine for awake craniotomy without laryngeal mask. Arq Neuropsiquiatr. 2005;63:748–50.
Mack PF, Perrine K, Kobylarz E, et al. Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol. 2004;16:20–5.
Souter MJ, Rozet I, Ojemann JG, et al. Dexmedetomidine sedation during awake craniotomy for seizure resection: effects on electrocorticography. J Neurosurg Anesthesiol. 2007;19:38–44.
Rozet I, Muangman S, Vavilala MS, et al. Clinical experience with dexmedetomidine for implantation of deep brain stimulators in Parkinson’s disease. Anesth Analg. 2006;103:1224–8.
Uyar AS, Yagmurdur H, Fidan Y, et al. Dexmedetomidine attenuates the hemodynamic and neuroendocrinal responses to skull-pin head-holder application during craniotomy. J Neurosurg Anesthesiol. 2008;20:174–9.
Rozet I. Anesthesia for functional neurosurgery: the role of dexmedetomidine. Curr Opin Anaesthesiol. 2008;21:537–43.
Khatib R, Ebrahim Z, Rezai A. Anesthetic complications during deep brain stimulation. Anesthesiology. 2004;101:A379.
Vitek JL, Bakay RA, Hashimoto T, et al. Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson’s disease. J Neurosurg. 1998;88(6):1027–43.
Bertrand C, Poirier L, Martinez N, et al. Pneumotaxic localization, recording, stimulation, and section of basal brain structures in dyskinesia. Neurology. 1958;8(10):783–6.
Bertrand G, Jasper H, Wong A. Microelectrode study of the human thalamus: functional organization in the ventro-basal complex. Confin Neurol. 1967;29(2):81–6.
Albe-Fessard D, Arfel G, Guiot G, et al. Electrophysiological studies of some deep cerebral structures in man. J Neurol Sci. 1966;3(1):37–51.
Albe-Fessard D. Electrophysiological methods for the identification of thalamic nuclei. Z Neurol. 1973;205(1):15–28.
Sterio D, Berić A, Dogali M, et al. Neurophysiological properties of pallidal neurons in Parkinson’s disease. Ann Neurol. 1994;35(5):586–91.
Alterman RL, Sterio D, Beric A, et al. Microelectrode recording during posteroventral pallidotomy: impact on target selection and complications. Neurosurgery. 1999;44(2):315–21.
Hutchison WD, Allan RJ, Opitz H, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson’s disease. Ann Neurol. 1998;44(4):622–8.
Forster A, Eljamel MS, Varma TR, et al. Audit of neurophysiological recording during movement disorder surgery. Stereotact Funct Neurosurg. 1999;72(2–4):154–6.
Zonenshayn M, Rezai AR, Mogilner AY, et al. Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting. Neurosurgery. 2000;47(2):282–92.
Hardy J. Electrophysiological localization and identification. J Neurosurg. 1966;24:410–4.
Lozano A, Hutchison W, Kiss Z, et al. Methods for microelectrode-guided posteroventral pallidotomy. J Neurosurg. 1996;84(2):194–202.
Bakay RA, DeLong MR, Vitek JL. Posteroventral pallidotomy for Parkinson’s disease. J Neurosurg. 1992;77(3):487–8.
Baron MS, Vitek JL, Bakay RA, et al. Treatment of advanced Parkinson’s disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol. 1996;40(3):355–66.
Sutton JP, Couldwell W, Lew MF, et al. Ventroposterior medial pallidotomy in patients with advanced Parkinson’s disease. Neurosurgery. 1995;36(6):1112–6.
Lang AE, Lozano AM, Montgomery E, et al. Posteroventral medial pallidotomy in advanced Parkinson’s disease. N Engl J Med. 1997;337(15):1036–42.
Iacono RP, Shima F, Lonser RR, et al. The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson’s disease. Neurosurgery. 1995;36(6):1118–25.
Laitinen LV, Bergenheim AT, Hariz MI. Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. Stereotact Funct Neurosurg. 1992;58(1–4):14–21.
Laitinen LV. Ventroposterolateral pallidotomy. Stereotact Funct Neurosurg. 1994;62(1–4):41–52.
Vitek JL. Deep brain stimulation for Parkinson’s disease. A critical re-evaluation of STN versus GPi DBS. Stereotact Funct Neurosurg. 2002;78(3–4):119–31.
Moreau C, Defebvre L, Destee A, et al. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology. 2008;71(2):80–4.
Brozova H, Barnaure I, Alterman RL, et al. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology. 2009;72(8):770.
Brotchie J, Fitzer-Attas C. Mechanisms compensating for dopamine loss in early Parkinson disease. Neurology. 2009;72(7 Suppl):S32–8.
Chesselet MF. Dopamine and Parkinson’s disease: is the killer in the house? Mol Psychiatry. 2003;8(4):369–70.
Ekesbo A, Rydin E, Torstenson R, et al. Dopamine autoreceptor function is lost in advanced Parkinson’s disease. Neurology. 1999;52(1):120–5.
Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson’s disease. Brain. 2002;125:575–83.
Benabid AL, Benazzouz A, Hoffmann D, et al. Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord. 1998;13 Suppl 3:119–25.
Vesper J, Chabardes S, Fraix V, et al. Dual channel deep brain stimulation system (Kinetra™) for Parkinson’s disease and essential tremor – a prospective multi-center open label clinical study. J Neurol Neurosurg Psychiatry. 2002;73:275–80.
Anderson VC, Burchiel KJ, Hogarth P, et al. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol. 2005;62:554–60.
Volkmann J, Allert N, Voges J, et al. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology. 2001;56:548–51.
Blomstedt P, Hariz MI. Are complications less common in deep brain stimulation than in ablative procedures for movement disorders? Stereotact Funct Neurosurg. 2006;84(2–3):72–81.
Alkhani A, Lozano AM. Pallidotomy for parkinson disease: a review of contemporary literature. J Neurosurg. 2001;94(1):43–9.
Beric A, Kelly PJ, Rezai A, et al. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg. 2001;77(1–4):73–8.
Mason LJ, Cojocaru TT, Cole DJ. Surgical intervention and anesthetic management of the patient with Parkinson’s disease. Int Anesthesiol Clin. 1996;34(4):133–50.
Nicholson G, Pereira AC, Hall GM. Parkinson’s disease and anaesthesia. Br J Anaesth. 2002;89(6):904–16.
Gross M, Bannister R, Godwin-Austen R. Orthostatic hypotension in Parkinson’s disease. Lancet. 1972;1(7743):174–6.
Vincken WG, Gauthier SG, Dollfuss RE, et al. Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med. 1984;311(7):438–42.
Lee KH. Oromandibular dystonia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(4):491–6.
Farmer SF, Sheean GL, Mayston MJ, et al. Abnormal motor unit synchronization of antagonist muscles underlies pathological co-contraction in upper limb dystonia. Brain. 1998;121(Pt 5):801–14.
Gracies J-M, Simpson DM. Spastic dystonia. In: Brin MF, Comella C, Jankovic J, editors. Dystonia etiology, clinical features, and treatment. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 195–212.
Zhang JG, Zhang K, Wang ZC, et al. Deep brain stimulation in the treatment of secondary dystonia. Chin Med J (Engl). 2006;119(24):2069–74.
Katsakiori PF, Kefalopoulou Z, Markaki E, et al. Deep brain stimulation for secondary dystonia: results in 8 patients. Acta Neurochir (Wien). 2009;151(5):473–8.
Sani S, Ostrem JL, Shimamoto S, et al. Single unit “pauser” characteristics of the globus pallidus pars externa distinguish primary dystonia from secondary dystonia and Parkinson’s disease. Exp Neurol. 2009;216(2):295–9.
Woehrle JC, Blahak C, Kekelia K, et al. Chronic deep brain stimulation for segmental dystonia. Stereotact Funct Neurosurg. 2009;87(6):379–84.
Schneider SA, Klein C. PINK1 type of young-onset Parkinson disease. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle: University of Washington; 2010. p. 1993–2010.
Raymond D, Bressman SB. Early-onset primary dystonia (DYT1). In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle: University of Washington; 2010. p. 1993–9.
Albanese A, Barnes MP, Bhatia KP, et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol. 2006;13(5):433–44.
Shils JL, Tagliati M, Alterman RL. Neurophysiological monitoring during neurosurgery for movement disorders. In: Deletis V, Shils JL, editors. Neurophysiology in neurosurgery: a modern intraoperative approach. Elsevier; New York City; 2002. p. 405–48.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Shils, J.L., Mokeem, A.A., Arle, J.E. (2012). Deep Brain Stimulation. In: Koht, A., Sloan, T., Toleikis, J. (eds) Monitoring the Nervous System for Anesthesiologists and Other Health Care Professionals. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0308-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0308-1_5
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-0307-4
Online ISBN: 978-1-4614-0308-1
eBook Packages: MedicineMedicine (R0)